Career inequality for women in ophthalmic research tops news of the week

Here are some of the top stories on Healio.com/OSN from the past week:

 

Women in ophthalmic research see career inequalities

The integration of women authorship in ophthalmic research is comparable to that of other medical specialties, but overall women authors are underrepresented when compared with men. Read more.

 

Tumor reduction sustained with fractionated stereotactic radiotherapy

Lesion reduction was sustained and visual function improved in eyes treated with fractionated stereotactic radiotherapy for cavernous venous malformation of the orbital apex. Read more.

 

Graybug Vision completes Series C financing

Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its potential glaucoma treatment GB-401 into the clinic. Read more.

 

Mixed phase 2a results reported for Oxurions anti-PlGF combined with anti-VEGF

The randomized, single-masked, active-controlled, multicenter study included 70 patients with diabetic macular edema who were treated with a combination of THR-317 and ranibizumab or ranibizumab and sham. Read more.

 

Vehicle pollution may increase AMD risk

Nearly 40,000 Taiwanese residents aged 50 years and older were enrolled in a longitudinal population-based study that used data from the Longitudinal Health Insurance Database and the Taiwan Air Quality Monitoring Database to investigate the risk for AMD after chronic exposure to ambient nitrogen dioxide and carbon monoxide. Read more.

Here are some of the top stories on Healio.com/OSN from the past week:

 

Women in ophthalmic research see career inequalities

The integration of women authorship in ophthalmic research is comparable to that of other medical specialties, but overall women authors are underrepresented when compared with men. Read more.

 

Tumor reduction sustained with fractionated stereotactic radiotherapy

Lesion reduction was sustained and visual function improved in eyes treated with fractionated stereotactic radiotherapy for cavernous venous malformation of the orbital apex. Read more.

 

Graybug Vision completes Series C financing

Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its potential glaucoma treatment GB-401 into the clinic. Read more.

 

Mixed phase 2a results reported for Oxurions anti-PlGF combined with anti-VEGF

The randomized, single-masked, active-controlled, multicenter study included 70 patients with diabetic macular edema who were treated with a combination of THR-317 and ranibizumab or ranibizumab and sham. Read more.

 

Vehicle pollution may increase AMD risk

Nearly 40,000 Taiwanese residents aged 50 years and older were enrolled in a longitudinal population-based study that used data from the Longitudinal Health Insurance Database and the Taiwan Air Quality Monitoring Database to investigate the risk for AMD after chronic exposure to ambient nitrogen dioxide and carbon monoxide. Read more.